Efficacy of Secukinumab in Patients With Moderate to Severe Hidradenitis Suppurativa With and Without Prior Biologic Exposure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Secukinumab in patients with moderate to severe hidradenitis suppurativa based on prior biologic exposure: An efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials
Br J Dermatol 2024 Mar 12;[EPub Ahead of Print], CC Zouboulis, T Passeron, D Pariser, MB Wozniak, X Li, L Uhlmann, I Lobach, AL Martinez, S Ravichandran, I Alarcon, A Offidani, MS Alam, P Mendes-BastosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.